Sweden Läkemedelsverket — Scandinavian GLP-1 prescribing update

Since we're doing Nordics — Finland quick update: Ozempic available, covered by Kela (social insurance) for T2D with a B-lausunto (medical statement). For obesity, not covered. Wegovy available privately at around €280/month. The Finnish system is more restrictive than Norway and Sweden for obesity medication coverage. I actually travel to Tallinn, Estonia to buy Ozempic at a lower price — about €85 per pen at Südameapteek pharmacies there.

the Estonia tip is clever. So for the full Nordic picture, Norway > Sweden > Denmark > Finland for obesity GLP-1 coverage. Fascinating how much variation there is among countries with supposedly similar healthcare philosophies.

The variation really comes down to how each country's HTA body evaluates cost-effectiveness. Norway's SLV used a broader societal perspective (including productivity gains and reduced cardiovascular events) which favored coverage. Sweden's TLV initially used a narrower healthcare perspective but revised their analysis. Denmark's Medicinrådet has been the most conservative. For anyone moving between Nordic countries — your medication history transfers through the Nordic e-health cooperation, so a new doctor in any Nordic country can see what you've been prescribed. Makes continuity of care much easier than moving between, say, European and non-European countries.